Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,460,196
Closed -$50.8M 25
2020
Q4
$50.8M Sell
1,460,196
-188,590
-11% -$5.32M 0.96% 17
2020
Q3
$28.6M Sell
1,648,786
-37,600
-2% -$655K 0.63% 19
2020
Q2
$27.7M Sell
1,686,386
-30,515
-2% -$464K 0.61% 22
2020
Q1
$15.6M Sell
1,716,901
-74,100
-4% -$1.49M 0.58% 17
2019
Q4
$38.1M Buy
1,791,001
+9,437
+0.5% +$209K 0.85% 11
2019
Q3
$40.9M Sell
1,781,564
-3,660
-0.2% -$83.4K 0.83% 13
2019
Q2
$43.3M Sell
1,785,224
-2,524
-0.1% -$51.9K 0.76% 16
2019
Q1
$23.2M Sell
1,787,748
-4,900
-0.3% -$85.8K 0.41% 18
2018
Q4
$27M Sell
1,792,648
-90,900
-5% -$2.35M 0.52% 17
2018
Q3
$74M Sell
1,883,548
-3,100
-0.2% -$140K 1.15% 14
2018
Q2
$92.8M Sell
1,886,648
-15,200
-0.8% -$862K 1.39% 13
2018
Q1
$114M Buy
1,901,848
+19,033
+1% +$1.27M 1.79% 13
2017
Q4
$148M Buy
1,882,815
+13,500
+0.7% +$1.09M 2.24% 13
2017
Q3
$157M Buy
1,869,315
+254,434
+16% +$18M 2.36% 12
2017
Q2
$106M Buy
+1,614,881
New +$110M 1.6% 14

Other funds holding ADNT

Edgar Wachenheim's ADNT Position: Q1 2021 in Review

Edgar Wachenheim sold out of Adient (ADNT) in Q1 2021, closing a stake of 1,460,196 shares — an estimated $50.8M sold.

Edgar Wachenheim first reported a position in ADNT in Q2 2017 and held it in 15 quarters. The position peaked at $157M in Q3 2017. 301 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

  • Edgar Wachenheim reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
  • Edgar Wachenheim sold 1,460,196 Adient shares in Q1 2021, an estimated $50.8M.
  • Edgar Wachenheim first reported a position in Adient in Q2 2017 and held it in 15 quarters.
  • Edgar Wachenheim's Adient position peaked at $157M in Q3 2017.
  • 301 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on Greenhaven Associates's 13F filing for Q1 2021, filed 13 May 2021.